Quality of Life Innovations from the Columbia University Department of Surgery

Four New Cancer Trials Now Enrolling Patients at the Pancreas Center

The Pancreas Center
Columbia University Medical Center
800-227-2762
The New York Optimist
Facebook
Twitter
Stumble
You Tube
Digg It
SHARE
© MMIX, The New York Optimist. All Rights Reserved. The New York Optimist & www.thenewyorkoptimist.com is a registered
trademark of The New York Optimist.  The New York Optimist is a registered service mark of Thenewyorkoptimist.com. The New York
Optimist logo and original photos are a registered trademark of The New York Optimist  . All other photos are property of the advertiser.
And are rightfully protected under their copywright protections.
To achieve its mission of improving detection and treatment
of pancreatic cancer, the
Pancreas Center maintains a
rigorous research program. Patients seeking treatment at
the center may be eligible to participate in one or more
trials, including the first trial of a non-invasive method of
screening for pancreatic cancer. By participating in trials,
patients can gain access to screening and therapeutic
modalities before they are available elsewhere, and their
participation helps to advance research efforts in pancreatic
cancer.
New trials in 2011 include:
Molecular Genetics and Epidemiology Study, to determine the frequency of gene mutations in patients with, or at a
high risk for developing, pancreatic cancer;
Depression and Tumor Burden in Pancreatic Adenocarcinoma Study, to assess the relationship between tumor size
and mood in pancreatic cancer;
Stool DNA Testing: A Feasibility Study, to evaluate the efficacy of detecting
pancreatic abnormalities in the stool; and
Registry and Tissue Bank for High Risk Individuals Study, to create a registry
of individuals with, or at high risk of developing, pancreatic cancer.
Participation in all studies is voluntary. Read more about all trials at the Center, and how you
may participate, by clicking
here.